Abstract:BackgroundIn the United States, about 3 million people have autism spectrum disorder (ASD), and around 1 out of 59 children are diagnosed with ASD. People with ASD have characteristic social communication deficits and repetitive behaviors. The causes of this disorder remain unknown; however, in up to 25% of cases, a genetic cause can be identified. Detecting ASD as early as possible is desirable because early detection of ASD enables timely interventions in children with ASD. Identification of ASD based on objective pathogenic mutation screening is the major first step toward early intervention and effective treatment of affected children. ObjectiveRecent investigation interrogated genomics data for detecting and treating autism disorders, in addition to the conventional clinical interview as a diagnostic test. Since deep neural networks perform better than shallow machine learning models on complex and high-dimensional data, in this study, we sought to apply deep learning to genetic data obtained across thousands of simplex families at risk for ASD to identify contributory mutations and to create an advanced diagnostic classifier for autism screening. MethodsAfter preprocessing the genomics data from the Simons Simplex Collection, we extracted top ranking common variants that may be protective or pathogenic for autism based on a chi-square test. A convolutional neural network–based diagnostic classifier was then designed using the identified significant common variants to predict autism. The performance was then compared with shallow machine learning–based classifiers and randomly selected common variants. ResultsThe selected contributory common variants were significantly enriched in chromosome X while chromosome Y was also discriminatory in determining the identification of autistic individuals from nonautistic individuals. The ARSD, MAGEB16, and MXRA5 genes had the largest effect in the contributory variants. Thus, screening algorithms were adapted to include these common variants. The deep learning model yielded an area under the receiver operating characteristic curve of 0.955 and an accuracy of 88% for identifying autistic individuals from nonautistic individuals. Our classifier demonstrated a considerable improvement of ~13% in terms of classification accuracy compared to standard autism screening tools. ConclusionsCommon variants are informative for autism identification. Our findings also suggest that the deep learning process is a reliable method for distinguishing the diseased group from the control group based on the common variants of autism.

Integrating genomic variants and developmental milestones to predict cognitive and adaptive outcomes in autistic children

Diagnostic Classification and Prognostic Prediction Using Common Genetic Variants in Autism Spectrum Disorder: Genotype-Based Deep Learning

Identifying the neurodevelopmental and psychiatric signatures of genomic disorders associated with intellectual disability: a machine learning approach

Copy-number variants and polygenic risk for intelligence confer risk for autism spectrum disorder irrespective of their effects on cognitive ability

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

Longitudinally stable, brain-based predictive models mediate the relationships between childhood cognition and socio-demographic, psychological and genetic factors

A Prediction Model of Autism Spectrum Diagnosis from Well-Baby Electronic Data Using Machine Learning

Genome-wide prediction of dominant and recessive neurodevelopmental disorder risk genes

Predicting autism traits from baby wellness records: A machine learning approach

Intellectual Development in Autism Spectrum Disorders: New Insights from Longitudinal Studies

Integrative genetic analysis: cornerstone of precision psychiatry

Genetic correlates of phenotypic heterogeneity in autism

Insights from an autism imaging biomarker challenge: Promises and threats to biomarker discovery

Artificial intelligence and bioinformatics analyze markers of children's transcriptional genome to predict autism spectrum disorder

Pre-treatment clinical and gene expression patterns predict developmental change in early intervention in autism

Latent trajectories of adaptive behaviour in infants at high and low familial risk for autism spectrum disorder

Exome functional risk score and brain connectivity can predict social adaptability outcome of children with autism spectrum disorder in 4 years' follow up

Parent attitudes towards predictive testing for autism in the first year of life

Innovative Computational Approaches Shed Light on Genetic Mechanisms Underlying Cognitive Impairment among Children Born Extremely Preterm

Discovering the gene-brain-behavior link in autism via generative machine learning

Development and validation of a risk score model for predicting autism based on pre- and perinatal factors